[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.180.70. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
August NaN, 2004

Antiphospholipid Testing and Outcome—Reply

Arch Intern Med. 2004;164(15):1701-1702. doi:10.1001/archinte.164.15.1701-c

In reply

We appreciate Drs Pechlaner and Wiedermann's interest in our article1 as well as their provocative clinical questions. Our work focused on establishing the impact of APS in the natural history of systemic lupus erythematosus (SLE). Thus we did not analyze the utility of aPL assay in predicting an adverse outcome before the development of APS, although this would be certainly relevant for clinicians looking after patients with lupus.

First Page Preview View Large
First page PDF preview
First page PDF preview
×